Data Sheet 1_Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective.pdf

Data Sheet 1_Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective.pdf

Background<p>The pharmacoinvasive (PhI) strategy is the standard-of-care for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (pPCI) is unfeasible. Optimal timing for post-fibrinolytic PCI (lysis-PCI) remains elusive. Therefore, this study aim...

Full description

Saved in:
Bibliographic Details
Main Author: Andrea Dias Stephanus (20555690) (author)
Other Authors: Alice Pacheco Santos (20555693) (author), Ana Carolina Machado Rodrigues da Cunha (20555696) (author), Ana Carolina Augusto Rocha (20555699) (author), Amanda de Amorim Meireles (20555702) (author), Mariana Guimarães Souza de Oliveira (20555705) (author), Pietra Arissa Coelho Matsunaga (20555708) (author), Alexandre Anderson de Sousa Munhoz Soares (14097108) (author), Ana Claudia Cavalcante Nogueira (12477954) (author), Adriana de J. B. de Almeida Guimarães (20555711) (author), Gustavo de Almeida Alexim (14097072) (author), Alessandra M. Campos-Staffico (14168103) (author), Luiz Sergio Fernandes de Carvalho (12477951) (author)
Published: 2025
Subjects:
Cardiology
ST-segment elevation myocardial infarction
fibrinolysis
percutaneous coronary intervention
pharmacoinvasive strategy
reperfusion strategy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items